NCT03711539

Brief Summary

The primary objective of the Master@Heart Trial is to investigate whether lifelong endurance exercise reduces the incidence of non-calcified plaques (both mixed and soft plaques) as compared to late-onset endurance exercise and a non-athletic lifestyle.

Trial Health

57
Monitor

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
1,800

participants targeted

Target at P75+ for all trials

Timeline
Completed

Started Oct 2018

Longer than P75 for all trials

Geographic Reach
1 country

3 active sites

Status
recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

October 17, 2018

Completed
1 day until next milestone

First Posted

Study publicly available on registry

October 18, 2018

Completed
Same day until next milestone

Study Start

First participant enrolled

October 18, 2018

Completed
3 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

October 1, 2021

Completed
4 years until next milestone

Study Completion

Last participant's last visit for all outcomes

October 1, 2025

Completed
Last Updated

July 3, 2024

Status Verified

July 1, 2024

Enrollment Period

3 years

First QC Date

October 17, 2018

Last Update Submit

July 2, 2024

Conditions

Keywords

Endurance ExerciseCoronary Artery DiseaseAtrial FibrillationMyocardial FibrosisCoronary CT

Outcome Measures

Primary Outcomes (1)

  • Incidence of Non-calcified Plaques

    Incidence of non-calcified plaques (both mixed and soft plaques) assessed by Coronary CT in lifelong endurance athletes as compared to late-onset endurance athletes and non-athletic subjects.

    2 years

Secondary Outcomes (2)

  • Incidence of Atrial Fibrillation

    4 years

  • Prevalence of Myocardial Fibrosis

    2 years

Other Outcomes (3)

  • Arterial Stiffness

    2 years

  • Carotid Intima Thickness

    2 years

  • Left Ventricular Diastolic Function

    2 years

Study Arms (3)

Lifelong Endurance Athletes

i) Athletes who have initiated endurance sports activities at regional, national or international level before the age of 30 years. Sports include triathlon, cycling, distance running (1500 metres and longer) and rowing. ii) Aged 45-70 years. iii) Involved in competition and high-level training: more than 10 hours per week for cyclists and triathletes or more than 6 hours per week for runners and rowers. Subjects will be excluded if: i) they have a history of smoking (\> 5 pack years) or diabetes, ii) had been diagnosed with a cardiopulmonary disorder prior to inclusion.

Late-onset Endurance Athletes

i) Athletes who have initiated endurance sports activities at regional, national or international level after the age of 30 years. Sports include triathlon, cycling, distance running (1500 metres and longer) and rowing. ii) Aged 45-70 years. iii) Involved in competition and high-level training: more than 10 hours per week for cyclists and triathletes or more than 6 hours per week for runners and rowers. Subjects will be excluded if: i) they have a history of smoking (\> 5 pack years) or diabetes, ii) they have a history of smoking (\> 5 pack years) or diabetes, ii) had been diagnosed with a cardiopulmonary disorder prior to inclusion.

Healthy Non-athletes

Healthy non-athletes will be recruited from subjects seen in the outpatient clinic for a work-related medical check-up, from university alumni and from multisports organisations. Subjects will be excluded if they: i) had been involved in regular sports practice more than \>3 hours / week, ii) have a history of smoking (\> 5 pack years) or diabetes, or iii) had been diagnosed with a cardiopulmonary disorder prior to inclusion. Participation in regular sports with a low dynamic component (e.g. billiards, darts or bowling) \>3 hours /week is allowed.

Eligibility Criteria

Age45 Years - 70 Years
Sexmale
Healthy VolunteersYes
Age GroupsAdult (18-64), Older Adult (65+)
Sampling MethodProbability Sample
Study Population

Cohort 1: Lifelong endurance athletes. Inclusions: Athletes who have initiated endurance sports activities at regional, national or international level before the age of 30 years. Sports include triathlon, cycling, distance running (1500 metres and longer) and rowing. Cohort 2: Late-onset endurance athletes. Athletes who have initiated endurance sports activities at regional, national or international level after the age of 30 years. Sports include triathlon, cycling, distance running (1500 metres and longer) and rowing. Cohort 3: Healthy non-athletes will be recruited from subjects seen in the outpatient clinic for a work-related medical check-up, from university alumni and from multisports organisations. Participation in regular sports with a low dynamic component (e.g. billiards, darts or bowling) \>3 hours /week is allowed.

You may qualify if:

  • Lifelong endurance athletes:
  • Initiation of endurance sports before the age of 30 years
  • Activities at regional, national or international level
  • Sports: triathlon, cycling, distance running (1500 metres and longer) and rowing
  • Aged 45-70 years
  • Involved in competition and high-level training:
  • more than 10 hours per week for cyclists and triathletes
  • more than 6 hours per week for runners and rowers.
  • Late-onset endurance athletes:
  • Initiation of endurance sports after the age of 30 years and at least 6 months ago
  • Activities at regional, national or international level
  • Sports: triathlon, cycling, distance running (1500 metres and longer) and rowing
  • Aged 45-70 years
  • Involved in competition and high-level training:
  • more than 10 hours per week for cyclists and triathletes
  • +7 more criteria

You may not qualify if:

  • history of smoking (\> 5 pack years)
  • history of diabetes
  • medical treatment for arterial hypertension or hypercholesterolemia

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (3)

University Hospital, Antwerpen

Edegem, 2650, Belgium

RECRUITING

Jessa Hospital

Hasselt, 3500, Belgium

RECRUITING

UZLeuven

Leuven, 3000, Belgium

RECRUITING

Related Publications (2)

  • Janssens K, Foulkes SJ, Mitchell AM, Dausin C, Van Soest S, Spencer L, Rowe SJ, D'Ambrosio P, Elliott AD, Van Puyvelde T, Parr EB, Willems R, Heidbuchel H, Claessen G, La Gerche A. Blood pressure response to graded bicycle exercise in males and females across the age and fitness spectrum. Eur J Prev Cardiol. 2025 Jan 6;32(1):43-51. doi: 10.1093/eurjpc/zwae262.

  • De Bosscher R, Dausin C, Claus P, Bogaert J, Dymarkowski S, Goetschalckx K, Ghekiere O, Belmans A, Van De Heyning CM, Van Herck P, Paelinck B, El Addouli H, La Gerche A, Herbots L, Heidbuchel H, Willems R, Claessen G. Endurance exercise and the risk of cardiovascular pathology in men: a comparison between lifelong and late-onset endurance training and a non-athletic lifestyle - rationale and design of the Master@Heart study, a prospective cohort trial. BMJ Open Sport Exerc Med. 2021 Apr 16;7(2):e001048. doi: 10.1136/bmjsem-2021-001048. eCollection 2021.

MeSH Terms

Conditions

Coronary Artery DiseaseMotor ActivityAtrial Fibrillation

Condition Hierarchy (Ancestors)

Coronary DiseaseMyocardial IschemiaHeart DiseasesCardiovascular DiseasesArteriosclerosisArterial Occlusive DiseasesVascular DiseasesBehaviorArrhythmias, CardiacPathologic ProcessesPathological Conditions, Signs and Symptoms

Central Study Contacts

Guido Claessen, MD, PhD

CONTACT

Study Design

Study Type
observational
Observational Model
COHORT
Time Perspective
PROSPECTIVE
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

October 17, 2018

First Posted

October 18, 2018

Study Start

October 18, 2018

Primary Completion

October 1, 2021

Study Completion

October 1, 2025

Last Updated

July 3, 2024

Record last verified: 2024-07

Locations